nifedipine has been researched along with Carcinoma, Signet Ring Cell in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McArthur, CP | 1 |
| Fiorella, R | 1 |
| Saran, BM | 1 |
1 other study available for nifedipine and Carcinoma, Signet Ring Cell
| Article | Year |
|---|---|
Rare primary signet ring carcinoma of the pancreas.
Topics: Aged; Carcinoma, Signet Ring Cell; Fatal Outcome; Female; Female Urogenital Diseases; Humans; Hypert | 1995 |